InspireMD, Inc. (NSPR) Stock

InspireMD, Inc. (NSPR) is a Healthcare stock trading at $0.73 (as of 2026-06-18), with a market capitalization of $73.73M and a trailing P/E of -1.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

InspireMD, Inc. develops and commercializes MicroNet stent platform technologies for vascular and coronary conditions, including CGuard carotid embolic prevention and MGuard Prime embolic protection systems, with PVGuard in peripheral applications. Products are sold via local distributors for use in Europe, Latin America, the Middle East, and Asia Pacific.

Valuation — source: SEC EDGAR (first-party)
Price$0.73
Market Cap$73.73M
P/E Ratio-1.3
EV / EBITDA0.1
Price / Book0.99
Price / Sales3.97
DCF Value (model)$-13.18
DCF Upside vs Price-1910.4%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$8.98M
Net Margin-543.3%
Return on Equity-117.6%
Current Ratio5.15
Revenue Growth (YoY)122.2%
EPS Growth (YoY)-27.3%
FCF Growth (YoY)36.9%
Financial Health — source: SEC EDGAR
Altman Z-Score-6.01 (distress)
Valuation vs Sector & Industry
Stock P/E-1.3
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector-106.3%
vs Industry-104.1%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderRosalind Advisors, Inc. ($6.37M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOMarvin L. Slosman
Employees85
CountryIL
IPO Date2011-04-12

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Pulmonx Corporation (LUNG)
  • Safe Pro Group Inc. Common Stock (SPAI)
  • Hyperfine, Inc. (HYPR)
  • PolyPid Ltd. (PYPD)
  • DarioHealth Corp. (DRIO)
  • Prenetics Global Limited (PRE)
  • Plus Therapeutics, Inc. (PSTV)
  • Outset Medical, Inc. (OM)
NSPR earnings history · NSPR institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.